We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+8.11%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$20.6B
AUM Growth
+$1.37B
(+7.1%)
Cap. Flow
-$6.1B
Cap. Flow
% of AUM
-29.59%
Top 10 Holdings %
Top 10 Hldgs %
22.72%
Holding
1,035
New
97
Increased
87
Reduced
313
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$63.7M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$52.7M |
| 3 |
HES
Hess
HES
|
+$42.5M |
| 4 |
SOVO
Sovos Brands, Inc. Common Stock
SOVO
|
+$35.1M |
| 5 |
AMED
Amedisys
AMED
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AESC
The AES Corporation
AESC
|
+$45.2M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$39.1M |
| 3 |
Mercado Libre
MELI
|
+$39M |
| 4 |
DEN
Denbury Inc.
DEN
|
+$26M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$25.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.31% |
| 2 | Healthcare | 8.45% |
| 3 | Financials | 7.73% |
| 4 | Consumer Discretionary | 7.1% |
| 5 | Communication Services | 5.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Becton Dickinson
BDX
$45.5B
| $16.2M | 0.08% |
66,596
-869
| -1% | -$214K |
|
177
Cigna
CI
$79.7B
| $16.1M | 0.08% |
53,627
-700
| -1% | -$205K |
|
178
Estee Lauder
EL
$30.7B
| $15.9M | 0.08% |
108,522
-1,734
| -2% | -$230K |
|
179
Caesars Entertainment
CZR
$6.11B
| $15.7M | 0.08% |
334,101
-2,647
| -0.8% | -$118K |
|
180
Target
TGT
$65.5B
| $15.4M | 0.07% |
108,044
-1,806
| -2% | -$220K |
|
181
Southern Company
SO
$110B
| $15.3M | 0.07% |
218,349
+1,322
| +0.6% | +$90.8K |
|
182
Verisk Analytics
VRSK
$28.1B
| $15.1M | 0.07% |
63,368
-828
| -1% | -$196K |
|
183
PayPal
PYPL
$51.7B
| $15M | 0.07% |
244,853
+97,776
| +66% | +$5.6M |
|
184
Allstate
ALL
$69.2B
| $15M | 0.07% |
106,842
-1,394
| -1% | -$182K |
|
185
HCA Healthcare
HCA
$90.4B
| $14.7M | 0.07% |
54,187
-708
| -1% | -$175K |
|
186
Vertiv
VRT
$103B
| $14.6M | 0.07% |
304,374
-89,603
| -23% | -$3.82M |
|
187
CALL
Alphabet (Google) Class A
GOOGL
$4.09T
| $14.5M | 0.07% |
+111,000
| New | +$14.9M |
|
188
Ulta Beauty
ULTA
$21.6B
| $14.5M | 0.07% |
29,633
-387
| -1% | -$163K |
|
|
BNY
189
Bank of New York Mellon
BNY
$106B
| $14.2M | 0.07% |
272,400
-3,559
| -1% | -$164K |
|
190
Edwards Lifesciences
EW
$48.5B
| $13.9M | 0.07% |
182,573
-3,080
| -2% | -$214K |
|
191
ASML
ASML
$608B
| $13.8M | 0.07% |
18,232
+13
| +0.1% | +$8.58K |
|
192
Lam Research
LRCX
$336B
| $13.7M | 0.07% |
175,500
+1,100
| +0.6% | +$75K |
|
193
Tyler Technologies
TYL
$13.7B
| $13.7M | 0.07% |
32,779
-389
| -1% | -$156K |
|
|
MNTN
194
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
| $13.7M | 0.07% |
1,250,000
| – | – |
|
195
Travelers Companies
TRV
$82.5B
| $13.7M | 0.07% |
71,687
-1,300
| -2% | -$225K |
|
|
DFS
196
DELISTED
Discover Financial Services
DFS
| $13.6M | 0.07% |
120,893
-1,579
| -1% | -$146K |
|
197
Ross Stores
ROST
$80.5B
| $13.6M | 0.07% |
98,021
-1,280
| -1% | -$159K |
|
198
Pentair
PNR
$10.5B
| $13.3M | 0.06% |
182,670
-2,386
| -1% | -$154K |
|
199
CALL
Microsoft
MSFT
$2.96T
| $13.2M | 0.06% |
41,800
-11,700
| -22% | -$4.16M |
|
200
Carnival Corporation Ltd
CCL
$38.7B
| $13M | 0.06% |
700,921
-8,381
| -1% | -$122K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Calamos Advisors held 1,035 positions worth $20.6B, up 7.1% from $19.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Calamos Advisors withdrew a net $6.1B in Q4 2023, closing 112 positions and reducing 313 holdings. Its most notable exit was The AES Corporation, an estimated $45.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Calamos Advisors opened a new position in Amedisys worth $23M.
- Calamos Advisors's largest Q4 2023 buy was Amedisys: 242,110 shares worth $23M.
- Calamos Advisors added most to Tesla in Q4 2023, an estimated $63.7M increase.
- Calamos Advisors's biggest Q4 2023 reduction was Mercado Libre, cutting an estimated $39M.
- Calamos Advisors fully exited The AES Corporation in Q4 2023, selling an estimated $45.2M.
- Calamos Advisors's ten largest holdings make up 23% of its $20.6B portfolio in Q4 2023.
- Calamos Advisors opened 97 new positions and closed 112 in Q4 2023.
- Calamos Advisors's portfolio value rose 7.1% quarter-over-quarter to $20.6B.
Based on Calamos Advisors's 13F filing for Q4 2023, filed 31 Jan 2024.